Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.12
-0.08-3.64%
Last update: Oct 6, 7:32 AM
$2.16
-0.04-1.82%
Xenetic Biosciences Inc (XBIO) Stock Price, Quote, News & History
XBIONASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immuno-oncology technologies addressing difficult-to-treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Xenetic Biosciences (NASDAQ:XBIO) through any online brokerage.
Other companies in Xenetic Biosciences’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
There is no analysis for Xenetic Biosciences to provide a consensus price target.
The stock price for Xenetic Biosciences (NASDAQ: XBIO) is $2.16 last updated October 6, 2026 at 7:32 AM EDT.
There are no upcoming dividends for Xenetic Biosciences.
Xenetic Biosciences does not have any upcoming earnings scheduled.
There is no upcoming split for Xenetic Biosciences.
Xenetic Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
